Advertisement

Picture Berlin Partner Life Sciences Report 2019/2020 Brandenburg 650x80px
Organisation › Details

BB Pureos Bioventures LP

Pureos Bioventures is a newly formed venture capital fund, advised by Bellevue Asset Management. Pureos invests exclusively in private innovative drug development companies, with a special emphasis on the next generation of biological drugs and drug formats. The fund’s portfolio companies are built on scientific excellence to develop therapies across a broad indication spectrum including oncology, immunology, ophthalmology, rare diseases, and neuroscience. Pureos has built a team with deep investment, operating, and clinical expertise, that strives to impact patients’ lives by advancing innovative treatments for devastating diseases. *

 

Period Start 2018-02-01 established (approx)
  Group Bellevue (Group)
Products Industry venture capital
  Industry 2 LIFE SCIENCES
Persons Person Escher, Dominik (Belleveue 201001 Managing Partner at BB Pureos Bioventures before ESBATech CEO + Founder)
  Person 2 Breiner, Klaus (BB Biotech Ventures + Vaximm 201605 Executive Chairman)
     
Region Region Guernsey
  Country United Kingdom (GB)
  Street Trafalgar Square
Les Banques
  City GY1 3QL St. Peter Port, Guernsey
    Address record changed: 2020-12-02
     
Basic data Employees n. a.
     
    * Document for �About Section�: BB Pureos Bioventures. (9/23/20). "Press Release: Pureos Bioventures Closes First Fund with USD 170 Million". St. Peter Port, Guernsey & Küsnacht.
     
   
Record changed: 2020-11-07

Advertisement

Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px

More documents for Bellevue (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture EBD Group BioTech Showcase 2021 Whitepaper Presenting 650x80




» top